AnalystsBenjamin HaynorBenjamin Haynor's Stock Forecasts
AnalystsBenjamin Haynor
Analyst Ranking
Top 42%
#2218 out of 5256 analysts
Average Return
+2.65%
Win Rate
46%6 out of 13
Risk vs Reward
Poor
Good
Benjamin Haynor's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Viasat IncVSAT | +131.87% | $12.77 | $29.61 | 2024-09-19 - 2025-09-19 | Strong Buy |
Surmodics IncSRDX | +97.46% | $27.55 | $54.40 | 2017-06-26 - 2018-06-27 | Strong Buy |
Profound Medical CorpPROF | +52.45% | $4.69 | $7.15 | 2025-04-22 - 2026-04-20 | Strong Buy |
Strata Critical Medical IncSRTA | +8.13% | $4.18 | $4.52 | 2025-12-01 - 2026-04-20 | Strong Buy |
Infusystem Holdings IncINFU | +3.65% | $10.41 | $10.79 | 2025-09-21 - 2026-04-20 | Strong Buy |
Benjamin Haynor Analyst Color
Get additional color on Benjamin Haynor's coverage of popular stocks
Benjamin Haynor's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Femasys IncFEMY | 1 | Strong Buy | $1.50 | +253.77% | Initiates Coverage On | 2 months ago |
Profound Medical CorpPROF | 2 | Strong Buy | $12.00 | +67.83% | Maintains | 3 months ago |
Strata Critical Medical IncSRTA | 1 | Strong Buy | $8.00 | +76.99% | Assumes | 5 months ago |
Infusystem Holdings IncINFU | 1 | Strong Buy | $15.00 | +39.02% | Assumes | 7 months ago |
Electromed IncELMD | 1 | Strong Buy | $36.00 | +41.73% | Assumes | 8 months ago |
Viasat IncVSAT | 5 | Strong Buy | $19.00 | N/A | Maintains | 2 years ago |
Cognyte Software LtdCGNT | 2 | Hold | N/A | N/A | Downgrades | 8 years ago |
Dariohealth CorpDRIO | 1 | Strong Buy | $1,400.00 | N/A | Initiates Coverage On | 9 years ago |
Surmodics IncSRDX | 1 | Strong Buy | $43.50 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.